Ventricular tachycardia in cardiac sarcoidosis: Characterization of ventricular substrate and outcomes of catheter ablation

Circulation: Arrhythmia and Electrophysiology

Volumn 8, Issue 1, 2015, Pages 87-93

  Kumar, Saurabh ^a   Barbhaiya, Chirag ^a   Nagashima, Koichi ^a   Choi, Eue Keun ^a   Epstein, Laurence M ^a   John, Roy M ^a   Maytin, Melanie ^a   Albert, Christine M ^a   Miller, Amy L ^a   Koplan, Bruce A ^a   Michaud, Gregory F ^a   Tedrow, Usha B ^a   Stevenson, William G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

arrhythmias, cardiac; catheter ablation; radiofrequency catheter ablation; tachycardia, ventricular

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; ANATOMICAL CONCEPTS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CONTROLLED STUDY; ELECTRIC POTENTIAL; ENDOCARDIUM; EPICARDIUM; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SCAR FORMATION; SURVIVAL; TREATMENT OUTCOME; ADVERSE EFFECTS; AGED; CARDIOMYOPATHIES; COMPLICATION; DISEASE FREE SURVIVAL; HEART FUNCTION TEST; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; RECURRENT DISEASE; RETREATMENT; TACHYCARDIA, VENTRICULAR; TIME;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHIES; CATHETER ABLATION; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETREATMENT; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923858083     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.114.002145     Document Type: Article

References (23)

1. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol. 2009;20:578-583. doi: 10.1111/j.1540-8167.2008.01417.x.
2. Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994;11:26-31.
3. Iwai K, Takemura T, Kitaichi M, Kawabata Y, Matsui Y. Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn. 1993;43:377-385.
4. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, Izumi T, Sekiguchi M; Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006-1010.
5. Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC, Cooper JM. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm. 2012;9:884-891. doi: 10.1016/j.hrthm.2012.02.010.
6. Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm. 2006;3:924-929. doi: 10.1016/j.hrthm.2006.03.031.
7. Jefic D, Joel B, Good E, Morady F, Rosman H, Knight B, Bogun F. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm. 2009;6:189-195. doi: 10.1016/j.hrthm.2008.10.039.
8. Tokuda M, Tedrow UB, Kojodjojo P, Inada K, Koplan BA, Michaud GF, John RM, Epstein LM, Stevenson WG. Catheter ablation of ventricular tachycardia in nonischemic heart disease. Circ Arrhythm Electrophysiol. 2012;5:992-1000. doi: 10.1161/CIRCEP.112.971341.
9. Soejima K, Stevenson WG, Maisel WH, Sapp JL, Epstein LM. Electrically unexcitable scar mapping based on pacing threshold for identification of the reentry circuit isthmus: feasibility for guiding ventricular tachycardia ablation. Circulation. 2002;106:1678-1683.
10. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288-1296.
11. Sosa E, Scanavacca M, d'Avila A, Oliveira F, Ramires JA. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol. 2000;35:1442-1449.
12. Stevenson WG, Friedman PL, Sager PT, Saxon LA, Kocovic D, Harada T, Wiener I, Khan H. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29:1180-1189.
13. Soejima K, Suzuki M, Maisel WH, Brunckhorst CB, Delacretaz E, Blier L, Tung S, Khan H, Stevenson WG. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation. 2001;104:664-669.
14. Haqqani HM, Tschabrunn CM, Tzou WS, Dixit S, Cooper JM, Riley MP, Lin D, Hutchinson MD, Garcia FC, Bala R, Verdino RJ, Callans DJ, Gerstenfeld EP, Zado ES, Marchlinski FE. Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications. Heart Rhythm. 2011;8:1169-1176. doi: 10.1016/j.hrthm.2011.03.008.
15. Polin GM, Haqqani H, Tzou W, Hutchinson MD, Garcia FC, Callans DJ, Zado ES, Marchlinski FE. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Heart Rhythm. 2011;8:76-83. doi: 10.1016/j. hrthm.2010.09.088.
16. Hutchinson MD, Gerstenfeld EP, Desjardins B, Bala R, Riley MP, Garcia FC, Dixit S, Lin D, Tzou WS, Cooper JM, Verdino RJ, Callans DJ, Marchlinski FE. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4:49-55. doi: 10.1161/CIRCEP.110.959957.
17. Yoshida K, Yokokawa M, Desjardins B, Good E, Oral H, Chugh A, Pelosi F, Morady F, Bogun F. Septal involvement in patients with postinfarction ventricular tachycardia: implications for mapping and radiofrequency ablation. J Am Coll Cardiol. 2011;58:2491-2500. doi: 10.1016/j. jacc.2011.09.014.
18. Sarkozy A, Tokuda M, Tedrow UB, Sieria J, Michaud GF, Couper GS, John R, Stevenson WG. Epicardial ablation of ventricular tachycardia in ischemic heart disease. Circ Arrhythm Electrophysiol. 2013;6:1115-1122. doi: 10.1161/CIRCEP.113.000467.
19. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63:86-108.
20. Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16:140-147. doi: 10.1111/j.1542-474X.2011.00418.x.
21. Stees CS, Khoo MS, Lowery CM, Sauer WH. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2011;22:210-213. doi: 10.1111/j.1540-8167.2010.01826.x.
22. Dechering DG, Kochhäuser S, Wasmer K, Zellerhoff S, Pott C, Köbe J, Spieker T, Piers SR, Bittner A, Mönnig G, Breithardt G, Wichter T, Zeppenfeld K, Eckardt L. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2013;10:158-164. doi: 10.1016/j.hrthm.2012.10.019.
23. Philips B, Madhavan S, James CA, te Riele AS, Murray B, Tichnell C, Bhonsale A, Nazarian S, Judge DP, Calkins H, Tandri H, Cheng A. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol. 2014;7:230-236. doi: 10.1161/ CIRCEP.113.000932.